Governance

After graduating in chemical engineering from the University of Bologna in 1972 at the age of 23, Luciano had a brief spell in the petrochemical industry before joining Dasco's BioMed R&D department, the European market leader at the time, together with Bellco. In 1980, Luciano became Head of Global R&D for hemofiltration at Amicon in Massachusetts, USA. In 1985, he returned to Italy and, together with Andrea Bocchi, founded Medica, initially as a research and development laboratory providing consultancy services to large multinational companies, and later as a true partner to the medical device manufacturing industry, having acquired expertise in electromedical equipment / automation with the acquisition of Tecnoideal in 1990.

Since then, Luciano has led the Medica Group into a pocket-sized multinational with world-class know-how in medical and water purification hollow fibre membranes and electromedical devices.

Luciano Fecondini was also President of the 'CONSOBIOMED Consortium', which brought together 24 Italian BioMed companies.

After graduating in Agricultural Science from the University of Bologna in 2004 and obtaining a Master's degree in Horticultural Science from the Technical University of Munich, Marco continued his academic career with a PhD from the University of Bologna, while working as a consultant in Peru, Burkina Faso and Brazil on food safety programmes and simplified hydroponic systems.

Marco joined Medica in 2011, initially in R&D - single-use products for blood purification, then as business developer of the Water Division (from 2012 to May 2021) and as Director (since 2015).

As of 2023, Marco holds the position of CEO (Chief Executive Officer)

After graduating in Economics in 2004 and obtaining a Master in Finance and Control at Profingest Management School in 2006, Giovanni undertook a professional path at PwC SpA - Audit for 15 years reaching the role of Senior Manager.

Giovanni joins Medica in 2021 with the role of Chief Financial Officer and for the entire period of Medica's listing he assumes the role of Investor Relator.

From 2022 he joins the Boards of Directors of some of the Group's subsidiaries.

Brad Pogalz is Donaldson’s Chief Financial Officer.

Most recently, he was Vice President, Global Financial Planning & Analysis and Europe Finance, based in Leuven, Belgium where he created Donaldson’s first global financial planning & analysis structure. Previously, Pogalz led Donaldson’s Investor Relations Corporate Communications, Sustainability and Enterprise Risk Management functions.

He holds a bachelor’s degree in finance from the University of St. Thomas and an MBA from the Carlson School of Management, University of Minnesota.